Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer
Titel:
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer
Auteur:
Douillard, Jean-Yves Peschel, Christian Shepherd, Frances Paz-Ares, Luis Arnold, Andrew Davis, Mary Tonato, Maurizio Smylie, Michael Tu, Dongsheng Voi, Maurizio Humphrey, Jeffrey Ottaway, Jon Young, Katherine Vreckem, Anne Van Seymour, Lesley